*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
Z79810 - Long term (current) use of selective estrogen receptor modulators (SERMs) - as a primary or secondary diagnosis code | ||
---|---|---|
OUTCOMES | ||
Avg. LOS | ||
Readmission Rate (%) | ||
Unplanned Readmission Rate (%) | 10.51 | |
Mortality Rate (%) | ||
SNF Discharge Rate (%) | ||
Home Discharge Rate (%) | ||
PAYMENTS AND CHARGES | ||
Total Medicare Payments | ||
Payment Per Day | ||
Payment Per Hospitalization | ||
Total Medicare Charges | ||
Avg. Charges | ||
MARKET SIZING & INCIDENCE RATES | ||
Total National Projected Hospitalizations - Annualized (Present on Admission - All) | ||
Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - All) | ||
Total National Projected Hospitalizations - Annualized (Present on Admission - Yes) | ||
Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Yes) | ||
Total National Projected Hospitalizations - Annualized (Present on Admission - Not Y) | ||
Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Not Y) | ||
Total Medicare Hospitalizations after Exclusion |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
DRG 470: MAJOR JOINT REPLACEMENT OR REATTACHMENT OF LOWER EXTREMITY WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 871: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 392: ESOPHAGITIS, GASTROENTERITIS AND MISCELLANEOUS DIGESTIVE DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 872: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 291: HEART FAILURE AND SHOCK WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
---|---|---|---|---|---|
Total Hospitalizations at DRG | 1,522,684 | ||||
Total Hospitalizations with ICD Z79810 - Long term (current) use of selective estrogen receptor modulators (SERMs) | 977 | ||||
DRG Share of Total Hospitalizations | 4.63 | ||||
% of Total ICD Z79810 - Long term (current) use of selective estrogen receptor modulators (SERMs) in DRG | 7.24 | ||||
Avg LOS at DRG | 2.52 | ||||
Avg LOS with ICD Z79810 - Long term (current) use of selective estrogen receptor modulators (SERMs) | 2.57 | ||||
Readmission Rate at DRG | 9.03 | ||||
Readmission Rate with ICD Z79810 - Long term (current) use of selective estrogen receptor modulators (SERMs) | 7.82 | ||||
Unplanned Readmission Rate at DRG | 3.35 | ||||
Unplanned Readmission Rate with ICD Z79810 - Long term (current) use of selective estrogen receptor modulators (SERMs) | 2.4 | ||||
Total Medicare payments at DRG | $17,672,828,347 | ||||
Total Medicare payments with ICD Z79810 - Long term (current) use of selective estrogen receptor modulators (SERMs) | $11,614,769 | ||||
Total Medicare payment per Day at DRG | $4,606 | ||||
Total Medicare payment per Day with ICD Z79810 - Long term (current) use of selective estrogen receptor modulators (SERMs) | $4,620 | ||||
Total Medicare payment per Hospitalization at DRG | $11,606 | ||||
Total Medicare payment per Hospitalization with ICD Z79810 - Long term (current) use of selective estrogen receptor modulators (SERMs) | $11,888 | ||||
Total Medicare Charges at DRG | $91,836,200,128 | ||||
Total Medicare Charges with ICD Z79810 - Long term (current) use of selective estrogen receptor modulators (SERMs) | $58,103,400 | ||||
Avg Charges at DRG | $60,312 | ||||
Avg Charges with ICD Z79810 - Long term (current) use of selective estrogen receptor modulators (SERMs) | $59,471 | ||||
Mortality Rate at DRG | 0.05 | ||||
Mortality Rate with ICD Z79810 - Long term (current) use of selective estrogen receptor modulators (SERMs) | NA | ||||
SNF Discharge Rate at DRG | 23.53 | ||||
SNF Discharge Rate with ICD Z79810 - Long term (current) use of selective estrogen receptor modulators (SERMs) | 26.61 | ||||
Home Discharge Rate at DRG | 30.67 | ||||
Home Discharge Rate with ICD Z79810 - Long term (current) use of selective estrogen receptor modulators (SERMs) | 25.79 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
DRG 690: KIDNEY AND URINARY TRACT INFECTIONS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 603: CELLULITIS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 190: CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 189: PULMONARY EDEMA AND RESPIRATORY FAILURE | DRG 194: SIMPLE PNEUMONIA AND PLEURISY WITH COMPLICATION OR COMORBIDITY (CC) | |
---|---|---|---|---|---|
Total Hospitalizations at DRG | 474,314 | ||||
Total Hospitalizations with ICD Z79810 - Long term (current) use of selective estrogen receptor modulators (SERMs) | 217 | ||||
DRG Share of Total Hospitalizations | 1.44 | ||||
% of Total ICD Z79810 - Long term (current) use of selective estrogen receptor modulators (SERMs) in DRG | 1.61 | ||||
Avg LOS at DRG | 3.53 | ||||
Avg LOS with ICD Z79810 - Long term (current) use of selective estrogen receptor modulators (SERMs) | 3.35 | ||||
Readmission Rate at DRG | 18.03 | ||||
Readmission Rate with ICD Z79810 - Long term (current) use of selective estrogen receptor modulators (SERMs) | 18.18 | ||||
Unplanned Readmission Rate at DRG | 12.55 | ||||
Unplanned Readmission Rate with ICD Z79810 - Long term (current) use of selective estrogen receptor modulators (SERMs) | 11.96 | ||||
Total Medicare payments at DRG | $2,312,733,090 | ||||
Total Medicare payments with ICD Z79810 - Long term (current) use of selective estrogen receptor modulators (SERMs) | $1,013,858 | ||||
Total Medicare payment per Day at DRG | $1,380 | ||||
Total Medicare payment per Day with ICD Z79810 - Long term (current) use of selective estrogen receptor modulators (SERMs) | $1,395 | ||||
Total Medicare payment per Hospitalization at DRG | $4,876 | ||||
Total Medicare payment per Hospitalization with ICD Z79810 - Long term (current) use of selective estrogen receptor modulators (SERMs) | $4,672 | ||||
Total Medicare Charges at DRG | $11,559,952,314 | ||||
Total Medicare Charges with ICD Z79810 - Long term (current) use of selective estrogen receptor modulators (SERMs) | $5,445,163 | ||||
Avg Charges at DRG | $24,372 | ||||
Avg Charges with ICD Z79810 - Long term (current) use of selective estrogen receptor modulators (SERMs) | $25,093 | ||||
Mortality Rate at DRG | 0.22 | ||||
Mortality Rate with ICD Z79810 - Long term (current) use of selective estrogen receptor modulators (SERMs) | NA | ||||
SNF Discharge Rate at DRG | 25.96 | ||||
SNF Discharge Rate with ICD Z79810 - Long term (current) use of selective estrogen receptor modulators (SERMs) | 23.5 | ||||
Home Discharge Rate at DRG | 43.58 | ||||
Home Discharge Rate with ICD Z79810 - Long term (current) use of selective estrogen receptor modulators (SERMs) | 49.77 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
DRG 378: G.I. HEMORRHAGE WITH COMPLICATION OR COMORBIDITY (CC) | DRG 176: PULMONARY EMBOLISM WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 683: RENAL FAILURE WITH COMPLICATION OR COMORBIDITY (CC) | DRG 193: SIMPLE PNEUMONIA AND PLEURISY WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 481: HIP AND FEMUR PROCEDURES EXCEPT MAJOR JOINT WITH COMPLICATION OR COMORBIDITY (CC) | |
---|---|---|---|---|---|
Total Hospitalizations at DRG | 408,103 | ||||
Total Hospitalizations with ICD Z79810 - Long term (current) use of selective estrogen receptor modulators (SERMs) | 168 | ||||
DRG Share of Total Hospitalizations | 1.24 | ||||
% of Total ICD Z79810 - Long term (current) use of selective estrogen receptor modulators (SERMs) in DRG | 1.25 | ||||
Avg LOS at DRG | 3.52 | ||||
Avg LOS with ICD Z79810 - Long term (current) use of selective estrogen receptor modulators (SERMs) | 3.26 | ||||
Readmission Rate at DRG | 17.83 | ||||
Readmission Rate with ICD Z79810 - Long term (current) use of selective estrogen receptor modulators (SERMs) | 14.81 | ||||
Unplanned Readmission Rate at DRG | 13.81 | ||||
Unplanned Readmission Rate with ICD Z79810 - Long term (current) use of selective estrogen receptor modulators (SERMs) | 12.35 | ||||
Total Medicare payments at DRG | $2,416,862,532 | ||||
Total Medicare payments with ICD Z79810 - Long term (current) use of selective estrogen receptor modulators (SERMs) | $969,969 | ||||
Total Medicare payment per Day at DRG | $1,682 | ||||
Total Medicare payment per Day with ICD Z79810 - Long term (current) use of selective estrogen receptor modulators (SERMs) | $1,773 | ||||
Total Medicare payment per Hospitalization at DRG | $5,922 | ||||
Total Medicare payment per Hospitalization with ICD Z79810 - Long term (current) use of selective estrogen receptor modulators (SERMs) | $5,774 | ||||
Total Medicare Charges at DRG | $13,267,744,847 | ||||
Total Medicare Charges with ICD Z79810 - Long term (current) use of selective estrogen receptor modulators (SERMs) | $5,324,647 | ||||
Avg Charges at DRG | $32,511 | ||||
Avg Charges with ICD Z79810 - Long term (current) use of selective estrogen receptor modulators (SERMs) | $31,694 | ||||
Mortality Rate at DRG | 0.72 | ||||
Mortality Rate with ICD Z79810 - Long term (current) use of selective estrogen receptor modulators (SERMs) | NA | ||||
SNF Discharge Rate at DRG | 14.1 | ||||
SNF Discharge Rate with ICD Z79810 - Long term (current) use of selective estrogen receptor modulators (SERMs) | 10.71 | ||||
Home Discharge Rate at DRG | 62.97 | ||||
Home Discharge Rate with ICD Z79810 - Long term (current) use of selective estrogen receptor modulators (SERMs) | 65.48 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
DRG 065: INTRACRANIAL HEMORRHAGE OR CEREBRAL INFARCTION WITH COMPLICATION OR COMORBIDITY (CC) OR TPA IN 24 HOURS | DRG 641: MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM , FLUIDS AND ELECTROLYTES WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 309: CARDIAC ARRHYTHMIA AND CONDUCTION DISORDERS WITH COMPLICATION OR COMORBIDITY (CC) | DRG 885: PSYCHOSES | DRG 292: HEART FAILURE AND SHOCK WITH COMPLICATION OR COMORBIDITY (CC) | |
---|---|---|---|---|---|
Total Hospitalizations at DRG | 352,097 | ||||
Total Hospitalizations with ICD Z79810 - Long term (current) use of selective estrogen receptor modulators (SERMs) | 153 | ||||
DRG Share of Total Hospitalizations | 1.07 | ||||
% of Total ICD Z79810 - Long term (current) use of selective estrogen receptor modulators (SERMs) in DRG | 1.13 | ||||
Avg LOS at DRG | 3.96 | ||||
Avg LOS with ICD Z79810 - Long term (current) use of selective estrogen receptor modulators (SERMs) | 3.45 | ||||
Readmission Rate at DRG | 35.38 | ||||
Readmission Rate with ICD Z79810 - Long term (current) use of selective estrogen receptor modulators (SERMs) | 36.0 | ||||
Unplanned Readmission Rate at DRG | 7.63 | ||||
Unplanned Readmission Rate with ICD Z79810 - Long term (current) use of selective estrogen receptor modulators (SERMs) | 7.33 | ||||
Total Medicare payments at DRG | $2,360,891,966 | ||||
Total Medicare payments with ICD Z79810 - Long term (current) use of selective estrogen receptor modulators (SERMs) | $891,224 | ||||
Total Medicare payment per Day at DRG | $1,693 | ||||
Total Medicare payment per Day with ICD Z79810 - Long term (current) use of selective estrogen receptor modulators (SERMs) | $1,688 | ||||
Total Medicare payment per Hospitalization at DRG | $6,705 | ||||
Total Medicare payment per Hospitalization with ICD Z79810 - Long term (current) use of selective estrogen receptor modulators (SERMs) | $5,825 | ||||
Total Medicare Charges at DRG | $13,014,640,264 | ||||
Total Medicare Charges with ICD Z79810 - Long term (current) use of selective estrogen receptor modulators (SERMs) | $5,612,787 | ||||
Avg Charges at DRG | $36,963 | ||||
Avg Charges with ICD Z79810 - Long term (current) use of selective estrogen receptor modulators (SERMs) | $36,685 | ||||
Mortality Rate at DRG | 1.54 | ||||
Mortality Rate with ICD Z79810 - Long term (current) use of selective estrogen receptor modulators (SERMs) | NA | ||||
SNF Discharge Rate at DRG | 24.0 | ||||
SNF Discharge Rate with ICD Z79810 - Long term (current) use of selective estrogen receptor modulators (SERMs) | 27.45 | ||||
Home Discharge Rate at DRG | 26.62 | ||||
Home Discharge Rate with ICD Z79810 - Long term (current) use of selective estrogen receptor modulators (SERMs) | 26.8 |
Hospital Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
---|---|---|---|---|---|
RIVERSIDE METHODIST HOSPITAL | 3535 OLENTANGY RIVER RD | COLUMBUS | OH | 43214 | 123 |
UF HEALTH SHANDS HOSPITAL | 1600 SW ARCHER RD | GAINESVILLE | FL | 32610 | 109 |
UNC REX HOSPITAL | 4420 LAKE BOONE TRL | RALEIGH | NC | 27607 | 94 |